The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.
about
A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival.Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer.Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function?Significant alterations in the expression pattern of kallikrein-related peptidase genes KLK4, KLK5 and KLK14 after treatment of breast cancer cells with the chemotherapeutic agents epirubicin, docetaxel and methotrexate.Evolving role of serum biomarkers in the management of ovarian cancer.
P2860
The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.
@ast
The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.
@en
type
label
The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.
@ast
The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.
@en
prefLabel
The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.
@ast
The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.
@en
P2093
Carsten Stephan
Dionyssios Katsaros
George M Yousef
John-Desmond Robb
Lisa Kurlender
Nader Memari
Nicole M A White
P2860
P2888
P304
P356
10.1159/000081384
P577
2004-09-01T00:00:00Z
P5875
P6179
1000939426